Transcriptional regualtion by the oncoprotein STAT5: role of acetylation/deacetylation and implications for STAT5-associated cancers
Transcriptional regualtion by the oncoprotein STAT5: role of acetylation/deacetylation and implications for STAT5-associated cancers
批准号:
170190027
负责人:
Privatdozentin Dr. Anne Rascle
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2015-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The signal transducer and activator of transcription STAT5 functions as an important downstream effector of cytokine signaling. It plays key roles in regulating immune responses, cell proliferation, differentiation, survival and oncogenesis. The mechanism by which STAT5 activates transcription is only starting to be unraveled. We have recently shown that a deacetylase activity is required for assembly of the transcriptional machinery and transcriptional activation by STAT5 (Rascle et al. 2003). We also demonstrated that this deacetylase activity is not targeting histone acetylation or chromatin remodeling (Rascle et al., 2003; Rascle and Lees, 2003), hence suggesting that it is targeting a non-histone protein required for transcriptional initiation by STAT5. The deacetylase and its substrate(s) represent potential targets for therapeutic intervention in STAT5-driven malignancies, and their identification has thus wide implications not only for a better understanding of STAT5 signaling but also in the clinical field. Accordingly, the main goals of our project are to: 1. identify the deacetylase involved in STAT5-mediated transcription, 2. identify the acetylated substrate, whose deacetylation is required for recruitment of the transcriptional machinery and transactivation by STAT5.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金